Autopsy report · NCT06530030
Goal Attainment and Physical Activity in People With Hemophilia A
Cause of deathFunding or business, also safety
“Early discontinuation based on sponsor decision not driven by any safety concerns.”
Life of this trial
- Registered 4 months before it started.
- Ran for about 10 months before it stopped.
- 3 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- Sanofi
- Sponsor type
- Industry
- Conditions
- Hemophilia A
- Interventions
- efanesoctocog alfa
- Participants
- 3
- Sites
- 1
- Countries
- United States
Trials that died the same way
- A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies
“Early discontinuation based on strategic sponsor decision not driven by any safety concerns.” - Futibatinib and Pembrolizumab Combination in the Treatment of Advanced or Metastatic Urothelial Carcinoma
“Sponsor decided to discontinue the study due to strategic considerations and not due to any safety-related concerns.” - REGENETEN™ Bioinductive Implant System in Full-thickness Tears
“Sponsor decision not related to safety.” - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
“Sponsor decision; the decision is not related to any safety concern.” - JSP191 Antibody Targeting Conditioning in SCID Patients
“Sponsor Decision - terminated due to changes in company priorities and not related to safety concerns.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.